Navigation Links
K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission
Date:12/27/2010

3)  the regulatory environment, including regulatory agency and judicial actions and changes in applicable laws or regulations, including the risk of obtaining necessary state licenses in a timely manner;

(14)  fluctuations in revenues;

(15)  the difficulty of predicting the pattern of inventory movements by the Company's customers;

(16)  the impact of competitive response to the Company's sales, marketing and strategic efforts, including introduction or potential introduction of generic or competing products against products sold by the Company and its subsidiaries, including Gestiva™, and including competitive pricing changes;

(17) risks that the Company may not ultimately prevail in litigation, including product liability lawsuits and challenges to its intellectual property rights by actual or potential competitors or to its ability to market generic products due to brand company patents and challenges to other companies' introduction or potential introduction of generic or competing products by third parties against products sold by the Company or its subsidiaries including without limitation the litigation and claims referred to in Note 15 – "Commitments and Contingencies" of the Notes to the Consolidated Financial Statements in the Form 10-K, and that any adverse judgments or settlements of such litigation, including product liability lawsuits, may be material to the Company;

(18)  the possibility that our current estimates of the financial effect of certain announced product recalls could prove to be incorrect;

(19) whether any product recalls or product introductions result in litigation, agency action or material damages;

(20)  failure to supply claims by certain of the Company's customers, including CVS Pharmacy, Inc., that, despite the formal discontinuation action by the Company of its products, the Company should compensate such customers for any additional costs
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... -- According to a new market ... Market ECG, Implantable Loop Recorder, Manual Event Monitor, ... Chamber Pacemaker, CRT-D, CRT-P - Global Forecast to ... (CM) and Cardiac Rhythm Management (CRM) Devices Market ... from $21,137.7 Million in 2015, at a CAGR ...
(Date:7/3/2015)... 2015  Obsidian HDS, the developer of PharmaShine ( ... the management of data on pharmaceutical and device industry ... includes the 2014 Open Payments General and Research data ... 30. The data disclosed on Open Payments for 2014 ... providers totaling $6.49 billion and is the largest public ...
(Date:7/2/2015)... 2, 2015 Leading organizations have increasingly ... product and market insights in internal market research ... studies, it is essential for executives to fully ... to capture critical business-related insights. According ... Practices, LLC, most benchmarked companies find it impossible ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Leveraging Employee Insights to Produce Cutting-Edge Market Research 2
... Perrigo Company (Nasdaq: PRGO ; TASE) today announced that ... 2010 on Monday, November 2, 2009 at approximately 8:00 a.m. ... 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo,s Chairman ... available live via webcast to interested parties on the Perrigo ...
... of Eli Lilly and Company (NYSE: LLY ) today declared ... share on outstanding common stock. This is the same dividend ... brings the total annual dividend for 2009 to $1.96 per share. ... dividend is payable December 10, 2009, to shareholders of record at ...
Cached Medicine Technology:
(Date:7/5/2015)... (PRWEB) , ... July 05, 2015 , ... Women’s ... and college) at their Lake Orion location. The special consists of 2 months of ... in Wellness, powered by Movestrong is located at 1410 South Lapeer Road in Lake ...
(Date:7/4/2015)... ... July 04, 2015 , ... Chronic Neck Pain. Neck ... sufferers have pain located in the neck. Another 19% suffer from head, migraine, or ... literature suggests that 45% of American workers must deal with neck pain. ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... enrollment on July 2nd creating a buzz of media attention. In an effort ... online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are feeling overwhelmed ...
(Date:7/3/2015)... ... ... rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. Rohrich , has ... from March 4th - 6th, the 2016 (a previous announcement had stated the dates ... take participants from the basic training and fundamentals of nasal surgery through the most ...
(Date:7/3/2015)... ... 2015 , ... Smoothies are all the rage right now and all you ... ingredients. Aurora Natural is proud to introduce a new line of all natural products ... vitamins and minerals! , Aurora is offering a variety of blends and stand-alone items ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2
... to minimise the risk of surface contamination in washrooms caused by the ... ... 2009 -- Did you know that flushing toilets ,sneeze, dirty water and ... bacteria such as E coli and risking the health and safety of ...
... The American College of Medical Genetics (ACMG) has joined ... Pathologists, and the American Society for Clinical Pathology in ... human genes associated with breast and ovarian cancer interfere ... regarding their health care. The lawsuit challenges patents on ...
... Inc. (Nasdaq: AHPI ) reported that its net ... from about $100,000, or 1 cent per share, in the ... a negative 6 cents per share, due to lower sales.Net ... $1.5 million, to about $12.4 million. Sales fell in ...
... With today,s release of the annual Social ... the nation,s two largest programs are on a ... to work together on reforms of both programs ... will need to recognize the underlying structural factors ...
... According to Latest Projections WASHINGTON , May 12 ... issued earlier today highlight the imperative to act immediately ... according to the American Academy of Actuaries . ... deteriorated further during the past year and inaction will ...
... 12 BioMed Realty Trust, Inc. (NYSE: BMR ... 14,000,000 shares of its common stock pursuant to an effective ... BioMed expects to use the net proceeds of the ... its $600.0 million unsecured line of credit and for other ...
Cached Medicine News:Health News:Pink Hygiene Issue Toilet Sneeze Warning for Workplaces 2Health News:ACMG Joins Lawsuit Challenging Patents on Breast Cancer Genes; Genes Are Naturally Occurring Substances and Should Not Be Patented, Says American College of Medical Genetics 2Health News:ACMG Joins Lawsuit Challenging Patents on Breast Cancer Genes; Genes Are Naturally Occurring Substances and Should Not Be Patented, Says American College of Medical Genetics 3Health News:Allied Healthcare Posts Third Quarter Loss 2Health News:Allied Healthcare Posts Third Quarter Loss 3Health News:Allied Healthcare Posts Third Quarter Loss 4Health News:Allied Healthcare Posts Third Quarter Loss 5Health News:Concord Coalition Says New Trustees' Report Demonstrates the Importance of Health Care Cost Control 2Health News:Actuaries: Trustees' Reports Warn of Looming Financial Challenges Facing Retirement Programs 2Health News:Actuaries: Trustees' Reports Warn of Looming Financial Challenges Facing Retirement Programs 3Health News:BioMed Realty Trust Announces Public Offering of 14,000,000 Shares of Common Stock 2Health News:BioMed Realty Trust Announces Public Offering of 14,000,000 Shares of Common Stock 3
... Microline Small Bone Power System combines ... performing under the most exacting conditions. ... for small bone osteotomies and oral/maxillofacial ... (extended length available), oscillating saw (extended ...
Circular Spine Retractor System for microsurgical interventions in the lumbar and cervical spine region. The system has been approved in over 120 cases....
... System incorporates specially designed metal tubes that ... in a minimally invasive manner. These tubes, ... 5.3 mm to 20.8 mm. The METRx ... one around the other - through the ...
The Telescopic Plate Spacer (TPS - C) Implants is an expandable titanium spacer designed to stabilize the spine following corpectomy/ vertebrectomy procedures....
Medicine Products: